Position:
Finance & Accounting, Controller (Sr Director/Executive Director/VP)
Department:
Finance and Accounting
Location:
Remote (PST Zone) with regular travel to Los Angeles office and periodic travel to Guangzhou, China office
Reports To:
CFO
Position Summary
The Finance & Accounting, Controller will play a critical role in the Company’s strategic financial leadership, preparing for IPO readiness initiatives, developing financial controls in anticipation of future Sarbanes-Oxley (SOX) compliance in a highly regulated environment, conversion from IFRS to GAAP accounting standards, transitioning to US-led financial audits, leading budgeting process and strengthening the Company’s financial planning and analysis (FP&A) capabilities. This position will partner closely with stakeholders to oversee the financial strategy and planning, manage risk, and optimize financial operations.
Responsibilities
- Lead finance team in preparation for and successful completion the company’s first PCAOB audit under US GAAP accounting standards.
- Oversee preparation of accurate, timely financial reports in compliance with US GAAP and future SEC reporting requirements. Manage quarterly and annual audits, tax filings, and board reporting.
- Strengthen the company’s financial controls, policies, and procedures in anticipation of PCAOB audits, potential IPO, and future SOX compliance. Continuously monitor and improve control frameworks to safeguard assets, financial reporting integrity, and regulatory compliance.
- Lead and manage all financial aspects of IPO readiness initiatives, including the development of IPO documentation, including supportive documentation for investor presentations. Oversee financial due diligence, including working closely with external auditors, legal teams, and investment banks to ensure seamless execution of IPO-related initiatives.
- Drive the financial planning process, including forecasting, budgeting, and long-term financial strategy. Provide insights and data reporting to the executive team to support decision-making for sustainable growth.
- Oversee adherence to federal, state, and industry-specific financial regulations. Implement risk management policies, systems, and strategies to minimize financial risk.
- Lead, mentor, and grow a high-performing finance and accounting team.
- Lead the Finance team to be tax compliant in different territories (including federal and states) and manage tax credit applications in different areas.
- Build and maintain strong relationships with stakeholders. Communicate financial strategies, risks, and results effectively.
- Perform other duties as requested.
Qualifications
- Bachelor’s degree in Accounting or Finance, advanced degree highly preferred.
- Professional certification such as Certified Internal Auditor (CIA), Certified Public Accountant (CPA), or Chartered Accountant (CA) is required.
- 15+ years of financing/auditing experience – with at least 10 years in internal control and audit within the bioscience industry.
- Big 4 firm experience highly preferred.
- Extensive experience with IPO readiness and executions.
- Experience in a US public company developing drug or biologic therapeutics, preferably as controller.
- Expert knowledge and understanding of US GAAP, SEC reporting requirements, and regulatory compliance frameworks in a public company setting.
- Proven track record in implementing and maintaining SOX-compliant controls and internal financial reporting systems.
- Demonstrated ability to lead, inspire, and develop teams in a dynamic, fast-paced environment.
- Passion for improving systems and processes.
- Excellent communication and collaboration skills.
- Bilingual (English and Chinese) would be ideal.
Salary Range:
$200,000 - $300,000
About Angitia
Established in June 2018, Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. Angitia is currently studying 3 biologic product candidates in the clinic for the treatment of osteoporosis (Phase 2), osteogenesis imperfecta (OI) (Phase 1), and spinal fusion (Phase 3). Leveraging the team's extensive experience and scientific acumen in novel drug development, Angitia is committed to providing groundbreaking therapies to satisfy key unmet medical needs. The founder and the core team members of Angitia are seasoned scientific leaders in new drug discovery, development, and management from both overseas and domestic large multinational companies. The company has built an organization with offices in Woodland Hills, CA and Guangzhou, China that is distinguished by world-class scientists with talents that are proficient in the pathophysiology of musculoskeletal diseases. We utilize cutting-edge technologies of genetics and molecular biology to uncover new mechanisms, signal transduction pathways and their interactions combined with computer aided drug design to identify new drug targets, and to discover and develop new biological and small molecule medicines. The company is committed to serving patients in need by carrying out innovative science including internal research and external collaborations with academics and global biopharmaceutical companies. We are seeking talented individuals who are innovative, ambitious, and great team players to join our vibrant group.
Learn more at www.angitiabio.com.
Benefits:
- Medical, dental, and vision coverage for employees and their eligible dependents
- 401(K) Retirement Plan with partial Company match
- Company paid Long Term Disability Coverage
- Company-paid life Insurance & AD&D Coverage
- Voluntary Life Insurance & AD&D Coverage
- Employee Assistance Program (EAP)
- Company-paid Holidays
- Paid Time Off
- Paid Sick Leave
- Telecommunication Monthly Stipend
- Work-From-Home Equipment Reimbursement
